ASEP Medical Holdings (XCNQ:ASEP) Gross Margin %: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XCNQ:ASEP ASEP Medical Holdings Inc XCNQ:ASEP
19 GF Score
Price C$0.13
! 4 Warning Signs
View Full Analysis

What is ASEP Medical Holdings Gross Margin %?

ASEP Medical Holdings XCNQ:ASEP 19 Gross Margin % is 0.00% as of Mar. 2026. GuruFocus rates XCNQ:ASEP with a GF Score™ of 19/100. The stock has 4 warning signs investors should review. Among 733 Biotechnology companies, ASEP Medical Holdings ranks better than 94.95% on this metric.

Gross Margin % is calculated as gross profit divided by its revenue. ASEP Medical Holdings's Gross Profit for the three months ended in Mar. 2026 was C$0.07 Mil. ASEP Medical Holdings's Revenue for the three months ended in Mar. 2026 was C$0.07 Mil. Therefore, ASEP Medical Holdings's Gross Margin % for the quarter that ended in Mar. 2026 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for ASEP Medical Holdings's Gross Margin % or its related term are showing as below:

XCNQ:ASEP' s Gross Margin % Range Over the Past 10 Years
Min: -542.86   Med: 32.89   Max: 97.63
Current: 97.63


During the past 5 years, the highest Gross Margin % of ASEP Medical Holdings was 97.63%. The lowest was -542.86%. And the median was 32.89%.

XCNQ:ASEP's Gross Margin % is ranked better than
94.95% of 733 companies
in the Biotechnology industry
Industry Median: 60.9 vs XCNQ:ASEP: 97.63

ASEP Medical Holdings had a gross margin of N/A% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for ASEP Medical Holdings was 0.00% per year.


ASEP Medical Holdings  (XCNQ:ASEP) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

ASEP Medical Holdings had a gross margin of N/A% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


ASEP Medical Holdings Gross Margin % Related Terms


ASEP Medical Holdings Gross Margin % Historical Data

* Premium members only.

The historical data trend for ASEP Medical Holdings's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ASEP Medical Holdings Gross Margin % Chart

ASEP Medical Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Gross Margin %
0.00 0.00 -542.86 32.89 97.03

ASEP Medical Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 98.63 59.46 118.67 106.96 0.00

XCNQ:ASEP vs VRTX, REGN, ALNY: Gross Margin % Comparison

For the Biotechnology subindustry, ASEP Medical Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ASEP Medical Holdings Gross Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ASEP Medical Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where ASEP Medical Holdings's Gross Margin % falls into.


XCNQ:ASEP
19GF Score
ASEP Medical Holdings Inc XCNQ:ASEP
Gross Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ASEP Medical Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

ASEP Medical Holdings's Gross Margin for the fiscal year that ended in Dec. 2025 is calculated as

Gross Margin % (A: Dec. 2025 )=Gross Profit (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=0.3 / 0.337
=(Revenue - Cost of Goods Sold) / Revenue
=(0.337 - 0.01) / 0.337
=97.03 %

ASEP Medical Holdings's Gross Margin for the quarter that ended in Mar. 2026 is calculated as


Gross Margin % (Q: Mar. 2026 )=Gross Profit (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=0.1 / 0.073
=(Revenue - Cost of Goods Sold) / Revenue
=(0.073 - 0) / 0.073
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of 0.00% mean?
ASEP Medical Holdings (XCNQ:ASEP) has a Gross Margin % of 0.00% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on ASEP Medical Holdings and its competitors. According to the industry distribution chart, ASEP Medical Holdings ranks #37 out of 733 companies in the Biotechnology industry, placing it in the top 5%.
Is ASEP Medical Holdings' Gross Margin % too high?
ASEP Medical Holdings' current Gross Margin % is 0.00%. Based on the distribution chart, ASEP Medical Holdings ranks #37 out of 733 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, ASEP Medical Holdings has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does ASEP Medical Holdings' Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, ASEP Medical Holdings ranks #37 out of 733 companies for Gross Margin %. This places ASEP Medical Holdings in the top 5% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 60.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.90, based on 733 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on ASEP Medical Holdings and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ASEP Medical Holdings's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASEP Medical Holdings stock overvalued right now?
ASEP Medical Holdings (XCNQ:ASEP) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. ASEP Medical Holdings' overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For ASEP Medical Holdings (XCNQ:ASEP), the current Gross Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ASEP Medical Holdings Business Description

Other Exchanges JJ80:Germany
Address 4400 Chatterton Way, Unit 202, Victoria, BC, CAN, V8X 5J2
ASEP Medical Holdings Inc is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. Diagnostic and therapeutic solutions represent tremendous clinical and commercial potential, through rapid diagnostics and uniquely effective treatments. Its Diagnostic has developed a novel diagnostic assay for the early and rapid risk assessment of sepsis. Therapeutic offering: Patented peptide technology targets infection-causing biofilms and reduces inflammation.
19GF Score

Get the complete analysis for XCNQ:ASEP

Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.13
Price